Information Journal Paper
APA:
CopyAGHAEI SHAHSAVARI, M., RASHTCHIZADEH, N., VEYSI, P., NOUROUZIAN AVAL, M., ARGANI, H., GHORBANI HAGHJOU, A., & BABAEI, HOSSEIN. (2006). ENALAPRIL AND LOSARTAN AFFECT LIPID PEROXIDATION IN RENAL TRANSPLANT RECIPIENTS WITH RENIN-ANGIOTENSIN SYSTEM POLYMORPHISMS. PHARMACEUTICAL SCIENCES, -(2), 33-40. SID. https://sid.ir/paper/48452/en
Vancouver:
CopyAGHAEI SHAHSAVARI M., RASHTCHIZADEH N., VEYSI P., NOUROUZIAN AVAL M., ARGANI H., GHORBANI HAGHJOU A., BABAEI HOSSEIN. ENALAPRIL AND LOSARTAN AFFECT LIPID PEROXIDATION IN RENAL TRANSPLANT RECIPIENTS WITH RENIN-ANGIOTENSIN SYSTEM POLYMORPHISMS. PHARMACEUTICAL SCIENCES[Internet]. 2006;-(2):33-40. Available from: https://sid.ir/paper/48452/en
IEEE:
CopyM. AGHAEI SHAHSAVARI, N. RASHTCHIZADEH, P. VEYSI, M. NOUROUZIAN AVAL, H. ARGANI, A. GHORBANI HAGHJOU, and HOSSEIN BABAEI, “ENALAPRIL AND LOSARTAN AFFECT LIPID PEROXIDATION IN RENAL TRANSPLANT RECIPIENTS WITH RENIN-ANGIOTENSIN SYSTEM POLYMORPHISMS,” PHARMACEUTICAL SCIENCES, vol. -, no. 2, pp. 33–40, 2006, [Online]. Available: https://sid.ir/paper/48452/en